Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengcheng Liu

Showing results (351-360 of 423) with videos related to

Pageof 43
Sort By:
Plos One|March 12, 2016
Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse ModelChengcheng Liu, Laura J Janke, Jitesh D Kawedia, et al.
Molecular Biotechnology|July 1, 2022
Whole-Genome Resequencing Deciphers New Insight Into Genetic Diversity and Signatures of Resistance in Cultivated Cotton Gossypium hirsutumAthar Hussain, Muhammad Farooq, Rubab Zahra Naqvi, et al.
Oncology Reports|June 8, 2019
Identification and characterization of a murine model of BCR‑ABL1+ acute B‑lymphoblastic leukemia with central nervous system metastasisXiaozhuo Yu, Hua Zhang, Meng Yuan, et al.
Materials Advances|August 12, 2021
Ultra-thin g-C<sub>3</sub>N<sub>4</sub>/MFM-300(Fe) heterojunctions for photocatalytic aerobic oxidation of benzylic carbon centersChengcheng Liu, Tian Luo, Alena M Sheveleva, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal womenMatt S Anderson, Isaias Noel Gendrano, Chengcheng Liu, et al.
Frontiers in Immunology|January 5, 2026
Lactylation: the metabolic-immune hub in autoimmune diseasesQingqing Xia, Dantong Sun, Ke Wan, et al.
Frontiers in Cell and Developmental Biology|November 12, 2021
Endothelial Dec1-PPARγ Axis Impairs Proliferation and Apoptosis Homeostasis Under Hypoxia in Pulmonary Arterial HypertensionXiaoming Li, Chengcheng Liu, Wenwen Qi, et al.
Lancet (London, England)|November 18, 2023
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USADavid W Dodick, Peter J Goadsby, Todd J Schwedt, et al.
Journal of Pineal Research|May 28, 2024
Circadian light/dark cycle reversal exacerbates the progression of chronic kidney disease in miceJiayang Zhang, Lejia Qiu, Zhaiyi Liu, et al.
Cephalalgia : an International Journal of Headache|November 26, 2020
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implicationsPeter J Goadsby, Andrew M Blumenfeld, Richard B Lipton, et al.
Pageof 43

Showing results (351-360 of 423) with videos related to

Sort By:
Pageof 43
Plos One|March 12, 2016
Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse ModelChengcheng Liu, Laura J Janke, Jitesh D Kawedia, et al.
Molecular Biotechnology|July 1, 2022
Whole-Genome Resequencing Deciphers New Insight Into Genetic Diversity and Signatures of Resistance in Cultivated Cotton Gossypium hirsutumAthar Hussain, Muhammad Farooq, Rubab Zahra Naqvi, et al.
Oncology Reports|June 8, 2019
Identification and characterization of a murine model of BCR‑ABL1+ acute B‑lymphoblastic leukemia with central nervous system metastasisXiaozhuo Yu, Hua Zhang, Meng Yuan, et al.
Materials Advances|August 12, 2021
Ultra-thin g-C<sub>3</sub>N<sub>4</sub>/MFM-300(Fe) heterojunctions for photocatalytic aerobic oxidation of benzylic carbon centersChengcheng Liu, Tian Luo, Alena M Sheveleva, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal womenMatt S Anderson, Isaias Noel Gendrano, Chengcheng Liu, et al.
Frontiers in Immunology|January 5, 2026
Lactylation: the metabolic-immune hub in autoimmune diseasesQingqing Xia, Dantong Sun, Ke Wan, et al.
Frontiers in Cell and Developmental Biology|November 12, 2021
Endothelial Dec1-PPARγ Axis Impairs Proliferation and Apoptosis Homeostasis Under Hypoxia in Pulmonary Arterial HypertensionXiaoming Li, Chengcheng Liu, Wenwen Qi, et al.
Lancet (London, England)|November 18, 2023
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USADavid W Dodick, Peter J Goadsby, Todd J Schwedt, et al.
Journal of Pineal Research|May 28, 2024
Circadian light/dark cycle reversal exacerbates the progression of chronic kidney disease in miceJiayang Zhang, Lejia Qiu, Zhaiyi Liu, et al.
Cephalalgia : an International Journal of Headache|November 26, 2020
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implicationsPeter J Goadsby, Andrew M Blumenfeld, Richard B Lipton, et al.
Pageof 43